Jounce Therapeutics, Inc.
Antibodies to PD-1 and uses thereof
Last updated:
Abstract:
Provided herein are various embodiments relating to antibodies. Some of the embodiments include antagonist antibodies that bind PD-1. Such antibodies can be used in methods to treat, for example, cancer.
Status:
Grant
Type:
Utility
Filling date:
1 Nov 2017
Issue date:
19 May 2020